The correlation between TSPO and AD markers (Aβ, Tau) in humans – and animal models [7]—and the reduction of Aβ and Tau density when TSPO is lowered suggest a cause-and-effect relationship and highlight the potential therapeutic impact of TSPO reduction. The gene discussed is MAPT; the disease is Alzheimer disease.